Artificial Organ & Bionics Market Growth, Industry Trends To 2020 by Grand View Research, Inc.
Increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates is expected to serve this market as a high impact rendering driver. For More Information Visit - http://www.grandviewresearch.com/industry-analysis/artificial-organ-and-bionics
Increasing prevalence of acute renal failure and renal disorders due to lifestyle habits such as excessive alcohol consumption and growing geriatric population base causing a rise in organ failure rates is expected to serve this market as a high impact rendering driver.
For More Information Visit - http://www.grandviewresearch.com/industry-analysis/artificial-organ-and-bionics
- No tags were found...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
Global <strong>Artificial</strong> <strong>Organ</strong> & <strong>Bionics</strong> <strong>Market</strong> By Product<br />
(<strong>Artificial</strong> Heart, Liver, Kidney, Pancreas, Bionic Limbs,<br />
Hear Valves, Cardiac, Vision), By Technology (Mechanical,<br />
Electronic) Expected to Reach USD 38.75 Billion By <strong>2020</strong>:<br />
<strong>Grand</strong> <strong>View</strong> <strong>Research</strong>, <strong>Inc</strong><br />
The global market for artificial organ and bionics is expected to reach USD 38.75 billion <strong>by</strong><br />
<strong>2020</strong> at an estimated CAGR of 9.3% from 2014 to <strong>2020</strong>, according to a new study <strong>by</strong> <strong>Grand</strong><br />
<strong>View</strong> <strong>Research</strong>, <strong>Inc</strong>. <strong>Inc</strong>reasing prevalence of acute renal failure and renal disorders due to<br />
lifestyle habits such as excessive alcohol consumption and growing geriatric population base<br />
causing a rise in organ failure rates is expected to serve this market as a high impact rendering<br />
driver. In addition, growing incidence rates of accidents is expected to boost the demand for<br />
organ transplants, thus increasing demand for artificial organ. <strong>Artificial</strong> kidney dominated the<br />
global market in 2013, with revenue estimated at over USD 12.21 billion; demand is expected<br />
grow due to the increasing chronic kidney patients. <strong>Artificial</strong> liver is the fastest growing market<br />
segment, at an estimated CAGR of 11.0% from 2014 to <strong>2020</strong>.<br />
<strong>View</strong> summary of this report @ http://www.grandviewresearch.com/industryanalysis/artificial-organ-and-bionics
Table of Contents<br />
Chapter 1. Executive Summary<br />
1.1. <strong>Artificial</strong> organ- <strong>Industry</strong> Summary & Critical Success Factors (CSFs)<br />
Chapter 2. <strong>Artificial</strong> organ <strong>Industry</strong> Outlook<br />
2.1. <strong>Market</strong> Segmentation<br />
2.2. <strong>Market</strong> Size and <strong>Growth</strong> Prospects<br />
2.3. <strong>Artificial</strong> organ <strong>Market</strong> Dynamics<br />
2.3.1. <strong>Market</strong> Driver Analysis<br />
2.3.2. <strong>Market</strong> Restraint Analysis<br />
2.4. Key Opportunities Prioritized<br />
2.5. <strong>Industry</strong> Analysis - Porter's<br />
2.6. <strong>Artificial</strong> organ- Company <strong>Market</strong> Share Analysis, 2013<br />
2.7. <strong>Artificial</strong> organ market PESTEL Analysis, 2013<br />
Chapter 3. <strong>Artificial</strong> organ Product Outlook<br />
3.1. <strong>Artificial</strong> organs<br />
3.1.1. Global artificial organ demand, (USD Million), 2012 – <strong>2020</strong><br />
3.1.1.1. Global total artificial heart demand, (USD Million), 2012 - <strong>2020</strong><br />
3.1.1.2. Global artificial pancreas demand, (USD Million), 2012 - <strong>2020</strong><br />
3.1.1.3. Global artificial liver demand, (USD Million), 2012 - <strong>2020</strong><br />
3.1.1.4. Global artificial lungs heart demand, (USD Million), 2012 - <strong>2020</strong><br />
3.1.1.5. Global artificial kidney heart demand, (USD Million), 2012 - <strong>2020</strong><br />
3.2. Bionic<br />
3.2.1. Global Bionic demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.1. Global Cochlear implants demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.2. Global Cardiac Bionic demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.3. Global Ventricular assist device demand, (USD Million), 2012 –<br />
<strong>2020</strong><br />
3.2.1.4. Global Heart valves demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.5. Global Mechanical valves demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.6. Global Biological tissue valves demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.7. Global Transcatheter heart valves demand, (USD Million), 2012 –<br />
<strong>2020</strong><br />
3.2.1.8. Global Brain bionics demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.9. Global Spinal cord stimulators demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.10. Global Deep brain stimulators demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.11. Global Vagus nerve stimulators demand, (USD Million), 2012 –<br />
<strong>2020</strong><br />
3.2.1.12. Global Exoskeletons demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.13. Global Bionic limbs demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.14. Global Bionic hands demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.15. Global Bionic legs demand, (USD Million), 2012 – <strong>2020</strong><br />
3.2.1.16. Global Vision bionics demand, (USD Million), 2012 – <strong>2020</strong>
Chapter 4. <strong>Artificial</strong> <strong>Organ</strong> Technology Outlook<br />
4.1. Mechanical bionics<br />
4.1.1. Global mechanical bionic demand, (USD Million), 2012 – <strong>2020</strong><br />
4.2. Electronic bionics<br />
4.2.1. Global electronic demand, (USD Million), 2012 – <strong>2020</strong><br />
Chapter 5. <strong>Artificial</strong> organ Regional Outlook<br />
5.1. North America<br />
5.1.1. North America artificial organmarket revenue <strong>by</strong> product, (USD Million),<br />
2012 – <strong>2020</strong><br />
5.1.2. North America artificial organmarket revenue <strong>by</strong> technology, (USD<br />
Million), 2012 - <strong>2020</strong><br />
5.2. Europe<br />
5.2.1. Europe artificial organmarket revenue <strong>by</strong> product, (USD Million), 2012 –<br />
<strong>2020</strong><br />
5.2.2. Europe artificial organmarket revenue <strong>by</strong> technology, (USD Million), 2012<br />
– <strong>2020</strong><br />
5.3. Asia Pacific<br />
5.3.1. Asia Pacific artificial organmarket revenue <strong>by</strong> product, (USD Million), 2012<br />
– <strong>2020</strong><br />
5.3.2. Asia Pacific artificial organmarket revenue <strong>by</strong> product technology, (USD<br />
Million), 2012 – <strong>2020</strong><br />
5.4. RoW<br />
5.4.1. RoW artificial organmarket revenue <strong>by</strong> product, (USD Million), 2012 –<br />
<strong>2020</strong><br />
5.4.2. RoW artificial organmarket revenue <strong>by</strong> product technology, (USD Million),<br />
2012 – <strong>2020</strong><br />
Chapter 6 Competitive Landscape<br />
6.1 Abiomed <strong>Inc</strong>.<br />
6.1.1 Company Overview<br />
6.1.2 Financial Performance<br />
6.1.3 Product Benchmarking<br />
6.1.4 Strategic Initiatives<br />
6.2 Asahi Kasei Kuraray Medical Co. Ltd.<br />
6.2.1 Company Overview<br />
6.2.2 Financial Performance<br />
6.2.3 Product Benchmarking<br />
6.2.4 Strategic Initiatives<br />
6.3 Thoratec Corporation<br />
6.3.1 Company Overview<br />
6.3.2 Financial Performance<br />
6.3.3 Product Benchmarking<br />
6.3.4 Strategic Initiatives<br />
6.4 WorldHeart Corp.<br />
6.4.1 Company Overview
6.4.2 Financial Performance<br />
6.4.3 Product Benchmarking<br />
6.4.4 Strategic Initiatives<br />
6.5 Gambro AB<br />
6.5.1 Company Overview<br />
6.5.2 Financial Performance<br />
6.5.3 Product Benchmarking<br />
6.5.4 Strategic Initiatives<br />
6.6 Biomet <strong>Inc</strong>.<br />
6.6.1 Company Overview<br />
6.6.2 Financial Performance<br />
6.6.3 Product Benchmarking<br />
6.6.4 Strategic Initiatives<br />
6.7 Cochlear Ltd<br />
6.7.1 Company Overview<br />
6.7.2 Financial Performance<br />
6.7.3 Product Benchmarking<br />
6.7.4 Strategic Initiatives<br />
6.8 Berlin Heart Gmbh<br />
6.8.1 Company Overview<br />
6.8.2 Financial Performance<br />
6.8.3 Product Benchmarking<br />
6.8.4 Strategic Initiatives<br />
6.9 Ekso <strong>Bionics</strong><br />
6.9.1 Company Overview<br />
6.9.2 Financial Performance<br />
6.9.3 Product Benchmarking<br />
6.9.4 Strategic Initiatives<br />
6.10 Medtronic <strong>Inc</strong>.<br />
6.10.1 Company Overview<br />
6.10.2 Financial Performance<br />
6.10.3 Product Benchmarking<br />
6.10.4 Strategic Initiatives<br />
6.11 Lifenet Health<br />
6.11.1 Company Overview<br />
6.11.2 Financial Performance<br />
6.11.3 Product Benchmarking<br />
6.11.4 Strategic Initiatives<br />
6.12 Heartware International <strong>Inc</strong>.<br />
6.12.1 Company Overview<br />
6.12.2 Financial Performance<br />
6.12.3 Product Benchmarking<br />
6.12.4 Strategic Initiatives<br />
6.13 Jarvik Heart <strong>Inc</strong>.
6.13.1 Company Overview<br />
6.13.2 Financial Performance<br />
6.13.3 Product Benchmarking<br />
6.13.4 Strategic Initiatives<br />
6.14 Walk <strong>Inc</strong>.Ossur<br />
6.14.1 Company Overview<br />
6.14.2 Financial Performance<br />
6.14.3 Product Benchmarking<br />
6.14.4 Strategic Initiatives<br />
6.15 Boston Scientific Corporation<br />
6.15.1 Company Overview<br />
6.15.2 Financial Performance<br />
6.15.3 Product Benchmarking<br />
6.15.4 Strategic Initiatives<br />
6.16 Sorin S.P.A.<br />
6.16.1 Company Overview<br />
6.16.2 Financial Performance<br />
6.16.3 Product Benchmarking<br />
6.16.4 Strategic Initiatives<br />
Chapter 7 Methodology and Scope<br />
7.1 <strong>Research</strong> Methodology<br />
7.2 <strong>Research</strong> Scope & Assumptions<br />
7.3 List of Data Sources<br />
Browse full report @ http://www.grandviewresearch.com/industry-analysis/artificialorgan-and-bionics<br />
List of Tables<br />
1. <strong>Artificial</strong> organ and medical bionics – <strong>Industry</strong> Summary & Critical Success Factors<br />
(CSFs)<br />
2. Global artificial organ and medical bionics market share (USD Million), 2013 & <strong>2020</strong><br />
3. Global artificial organ market <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
4. Global total artificial heart market (USD Million), 2012 - <strong>2020</strong><br />
5. Global artificial liver market (USD Million), 2012 - <strong>2020</strong><br />
6. Global artificial pancreas market (USD Million), 2012 - <strong>2020</strong><br />
7. Global artificial lungs market (USD Million), 2012 - <strong>2020</strong><br />
8. Global artificial kidney market (USD Million), 2012 - <strong>2020</strong><br />
9. Global bionics market <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
10. Global cochlear implants market (USD Million), 2012 - <strong>2020</strong><br />
11. Global cardiac bionics market <strong>by</strong> product (USD Million), 2012 – <strong>2020</strong>
12. Global heart valvesmarket <strong>by</strong> product(USD Million), 2012 - <strong>2020</strong><br />
13. Global mechanical valves market (USD Million), 2012 - <strong>2020</strong><br />
14. Global transcatheter heart valve market (USD Million), 2012 - <strong>2020</strong><br />
15. Global ventricular assist device market (USD Million), 2012 - <strong>2020</strong><br />
16. Global Bionic limbs market <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
17. Global bionic legs market (USD Million), 2012 - <strong>2020</strong><br />
18. Global bionic hands market (USD Million), 2012 - <strong>2020</strong><br />
19. Global brain bionic market <strong>by</strong> product(USD Million), 2012 - <strong>2020</strong><br />
20. Global deep brain stimulators market (USD Million), 2012 - <strong>2020</strong><br />
21. Global spinal cord stimulators market (USD Million), 2012 - <strong>2020</strong><br />
22. Global vagus nerves stimulators market (USD Million), 2012 - <strong>2020</strong><br />
23. Global vision bionics market (USD Million), 2012 - <strong>2020</strong><br />
24. Global artificial organ market <strong>by</strong> technology (USD Million), 2013 & <strong>2020</strong><br />
25. Global mechanical bionics market (USD Million), 2012 - <strong>2020</strong><br />
26. Global mechanical bionics market (USD Million), 2012 - <strong>2020</strong><br />
27. Global electronic bionics market (USD Million), 2012 - <strong>2020</strong><br />
28. North America artificial organmarket <strong>by</strong> product (USD Million), 22012 - <strong>2020</strong><br />
29. Europe artificial organmarket <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
30. Asia Pacific artificial organmarket <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
31. RoW artificial organmarket <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
For More Information visit http://www.grandviewresearch.com/industryanalysis/artificial-organ-and-bionics<br />
List of Figures<br />
1. <strong>Artificial</strong> organ <strong>Market</strong> Segmentation<br />
2. Global artificial organ and medical bionics market (USD Million), 2012 - <strong>2020</strong><br />
3. <strong>Artificial</strong> organvalue chain analysis<br />
4. <strong>Artificial</strong> organand medical bionics market dynamics<br />
5. <strong>Artificial</strong> organ- Company market share analysis, 2013<br />
6. Key Opportunities Prioritized<br />
7. <strong>Industry</strong> Analysis - Porter's<br />
8. <strong>Artificial</strong> organ PESTEL Analysis, 2013<br />
9. <strong>Artificial</strong> organ and bionic market share <strong>by</strong> product, 2012 – <strong>2020</strong><br />
10. <strong>Artificial</strong> organ and bionic market share <strong>by</strong> technology, 2012 - <strong>2020</strong><br />
11. <strong>Artificial</strong> organ and bionic market share <strong>by</strong> region, 2012 - <strong>2020</strong><br />
12. North America artificial organand bionic market, <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
13. North America artificial organ and bionicmarket, <strong>by</strong> technology (USD Million), 2012 –<br />
<strong>2020</strong><br />
14. Europe artificial organ and bionic market, <strong>by</strong> product (USD Million), 2012 – <strong>2020</strong>
15. Europe artificial organand bionic market, <strong>by</strong> technology (USD Million), 2012 - <strong>2020</strong><br />
16. Asia Pacific artificial organ and bionicmarket, <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
17. Asia Pacific artificial organ and bionicmarket, <strong>by</strong> technology (USD Million), 2012 - <strong>2020</strong><br />
18. RoW artificial organ and bionic market, <strong>by</strong> product (USD Million), 2012 - <strong>2020</strong><br />
19. RoW artificial organand bionic market, <strong>by</strong> technology (USD Million), 2012 - <strong>2020</strong><br />
Further key findings from the study suggest:<br />
<br />
<br />
Brain bionics in the medical bionics market held the largest share of revenue for the year<br />
2013 and the market is expected to grow at an estimated CAGR of 40.0%.The presence<br />
of high unmet medical needs in neurology disease segment coupled with expensive<br />
treatment procedures is expected to drive the market for brain bionics. Exoskeleton is the<br />
fastest growing segment and is expected to grow at a CAGR of 16.0% from 2014 to<br />
<strong>2020</strong>.<br />
North America was the largest regional market in 2013, accounting for over 42.0% of<br />
global revenue due to the increasing population and awareness among the patients and<br />
the players.<br />
Asia Pacific is the fastest growing market and is expected to grow at a CAGR of 11.0%<br />
from 2014 to <strong>2020</strong> on account of rising demand due to the improvement in healthcare<br />
facilities, medical tourism and others.<strong>Inc</strong>reasing income levels and healthcare<br />
expenditure is expected to interest of the players’ in the emerging markets.<br />
<br />
Key industry participants include Abiomed <strong>Inc</strong>., Asahi Kasei Kuraray Medical Co. Ltd.,<br />
Thoratec Corporation, WorldHeart Corp., Gambro AB and others.<br />
Request free sample of this Report @ http://www.grandviewresearch.com/industryanalysis/artificial-organ-and-bionics/request<br />
For the purpose of this study, <strong>Grand</strong> <strong>View</strong> <strong>Research</strong> has segmented the global artificial organ and<br />
bionics market on the basis of product, technology and region:<br />
<strong>Artificial</strong> <strong>Organ</strong> Product Outlook<br />
• <strong>Artificial</strong> organs
• <strong>To</strong>tal artificial heart<br />
• <strong>Artificial</strong> liver<br />
• <strong>Artificial</strong> pancreas<br />
• <strong>Artificial</strong> lungs<br />
• <strong>Artificial</strong> kidney<br />
• <strong>Bionics</strong><br />
• Cochlear implants<br />
• Exoskeletons<br />
• Cardiac bionics<br />
• Heart valves<br />
• Biological tissue valves<br />
• Mechanical valves<br />
• Transcatheter heart valves<br />
• Ventricular assist device<br />
• Bionic limbs<br />
• Bionic legs<br />
• Bionic hands<br />
• Brain bionics<br />
• Deep brain stimulators<br />
• Spinal cord stimulators<br />
• Vagus nerves stimulators<br />
• Vision bionics
<strong>Artificial</strong> <strong>Organ</strong> Technology Outlook<br />
• Mechanical bionics<br />
• Electronic bionics<br />
<strong>Artificial</strong> <strong>Organ</strong> Regional Outlook<br />
• North America<br />
• Europe<br />
• Asia Pacific<br />
• RoW<br />
Browse All Reports of this category @<br />
http://www.grandviewresearch.com/industry/healthcare-it<br />
About <strong>Grand</strong> <strong>View</strong> <strong>Research</strong><br />
<strong>Grand</strong> <strong>View</strong> <strong>Research</strong>, <strong>Inc</strong>. is a market research and consulting company that provides off-theshelf,<br />
customized research reports and consulting services. <strong>To</strong> help clients make informed<br />
business decisions, we offer market intelligence studies ensuring relevant and fact-based research<br />
across a range of industries, from technology to chemicals, materials and energy. With a deepseated<br />
understanding of varied business environments, <strong>Grand</strong> <strong>View</strong> <strong>Research</strong> provides strategic<br />
objective insights.<br />
Contact:<br />
Sherry James<br />
Corporate Sales Specialist, U.S.A.<br />
<strong>Grand</strong> <strong>View</strong> <strong>Research</strong>, <strong>Inc</strong>.<br />
United States<br />
Phone: 1-415-349-0058<br />
<strong>To</strong>ll Free: 1-888-202-9519<br />
Email: sales@grandviewresearch.com<br />
Website: <strong>Grand</strong> <strong>View</strong> <strong>Research</strong><br />
Blog Site: http://www.divog.org/
Change language